Clinical Trials on Human Papilloma Virus, Male in Hong Kong
Total 331 results
-
Humanity & Health Medical Group LimitedRecruitingChronic Hepatitis BHong Kong
-
Humanity & Health Medical Group LimitedWithdrawnHCV InfectionHong Kong
-
The University of Hong KongSuspendedInfluenza, HumanHong Kong
-
The University of Hong KongWithdrawn
-
The University of Hong KongCompleted
-
The University of Hong KongResearch Grant CouncilRecruitingCirrhosis | NAFLD | Chronic Hepatitis b | Fibrosis, Liver | Empagliflozin | SGLT2 InhibitorsHong Kong
-
The University of Hong KongCompletedExposure to Hepatitis B VirusHong Kong
-
The University of Hong KongRecruiting
-
Chinese University of Hong KongRecruiting
-
Chinese University of Hong KongRecruiting
-
The University of Hong KongNational Institute of Allergy and Infectious Diseases (NIAID); University of...Active, not recruitingInfluenza, HumanHong Kong
-
The University of Hong KongCompleted
-
The University of Hong KongUnknown
-
The University of Hong KongCompletedExposure to Hepatitis B VirusHong Kong
-
Sanwa BioTech LimitedChinese University of Hong Kong; Prince of Wales Hospital, Shatin, Hong KongNot yet recruiting
-
The University of Hong KongRecruitingLiver Transplant; Complications | Occult Hepatitis BHong Kong
-
The University of Hong KongFood and Health Bureau, Hong KongCompletedPregnancy | Infectious Disease | InfluenzaHong Kong
-
The University of Hong KongCompletedHepatitis B | Liver Dysfunction | Immune SuppressionHong Kong
-
F-star Therapeutics, Inc.PRA Health SciencesTerminatedHepatitis B | Hepatitis B, Chronic | HBVHong Kong
-
The University of Hong KongResearch Grants Council, Hong Kong; Research Fund for the Control of Infectious... and other collaboratorsCompletedInfluenza Virus InfectionChina
-
The University of Hong KongUnknown
-
Chinese University of Hong KongBioCryst PharmaceuticalsCompleted
-
The University of Hong KongHospital Authority, Hong KongCompleted
-
Novartis PharmaceuticalsCompleted
-
Chinese University of Hong KongUniversity of MalayaTerminatedImmunosuppression | Occult Hepatitis B | Biological Substance; Adverse EffectHong Kong
-
The University of Hong KongCompleted
-
The University of Hong KongCompletedChronic Hepatitis BHong Kong
-
The University of Hong KongGilead SciencesCompleted
-
Chinese University of Hong KongCompletedChronic Hepatitis BHong Kong
-
Chinese University of Hong KongCompletedInfluenza | Lower Respiratory Tract InfectionHong Kong
-
Humanity and Health Research CentreRecruitingChronic Hepatitis BHong Kong
-
The University of Hong KongCenters for Disease Control and Prevention; Hospital Authority, Hong KongActive, not recruitingInfluenza, HumanChina
-
The University of Hong KongUnknown
-
The University of Hong KongCenters for Disease Control and PreventionActive, not recruiting
-
Chinese University of Hong KongCompleted
-
Chinese University of Hong KongHoffmann-La RocheCompletedRespiratory Tract Infections | InfluenzaHong Kong
-
Centers for Disease Control and PreventionThe University of Hong KongCompleted
-
Hospital Authority, Hong KongThe University of Hong KongUnknown
-
The University of Hong KongCompleted
-
The University of Hong KongCompleted
-
Hospital Authority, Hong KongCompleted
-
The University of Hong KongHospital Authority, Hong KongCompletedChronic Hepatitis B InfectionHong Kong
-
Hospital Authority, Hong KongVigconic (International) Ltd.CompletedLiver Cirrhosis | Hepatitis B | Hepatitis CChina
-
The University of Hong KongCompletedAcute Respiratory Infection | Influenza-like Illness | Influenza Virus InfectionHong Kong
-
The University of Hong KongCompletedHepatitis B | Inflammatory Bowel DiseasesChina
-
The University of Hong KongNovartis PharmaceuticalsCompleted
-
The University of Hong KongCompletedHepatitis B, ChronicChina
-
Tibotec Pharmaceuticals, IrelandCompleted
-
The University of Hong KongCompleted
-
Humanity and Health Research CentreUniversity of Maryland; Emory University; Beijing 302 HospitalWithdrawn